Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 5:7:1947.
doi: 10.3389/fmicb.2016.01947. eCollection 2016.

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa

Affiliations

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa

Ivy Rukasha et al. Front Microbiol. .

Abstract

Treatment of tuberculosis (TB) and HIV co-infections is often complicated by drug-to-drug interactions between anti-mycobacterial and anti-retroviral agents. Rifabutin (RFB) is an alternative to rifampin (RIF) for TB regimens and is recommended for HIV patients concurrently receiving protease inhibitors because of reduced induction of CYP3A4. This study sought to determine the proportion of RFB susceptible isolates among RIF-resistant strains in a high HIV prevalence setting in South Africa. In addition, the study explored the association between rpoB mutations and minimum inhibitory concentrations (MIC) of RIF and RFB. A total of 189 multidrug resistant (MDR) Mycobacterium tuberculosis isolates from the Centre for Tuberculosis repository were analyzed. The MICs were determined using a MYCOTB Sensititre plate method and the rpoB gene was sequenced. Of the 189 MDR isolates, 138 (73%) showed resistance to both RIF and RFB, while 51 (27%) isolates were resistant to RIF but retained susceptibility to RFB. The S531L was the most frequent rpoB point mutation in 105/189 (56%) isolates, followed by H526Y in 27/189 (14%) isolates. Resistance to both RIF and RFB was found predominantly in association with mutations S531L (91/105, 87%), H526Y (20/27, 74%), and H526D (15/19, 79%), while D516V (15/17, 88%), and L533P (3/4, 75%) were found in RIF-resistant, RFB-susceptible isolates. This study has shown that up to 27% of MDR-TB patients in South Africa may benefit from a treatment regimen that includes RFB.

Keywords: HIV/AIDS; Mycobacterium tuberculosis; South Africa; minimum inhibitory concentration; point mutation; rifabutin; rifampicin; rpoB.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Comparison of RIF and RIFB MIC ranges and medians by rpoB mutations. A kruskal-Wallis test was used to show the association of MIC levels of RIF and RIFB with the rpoB mutations. The eclplot was constructed with Stata 14.

Similar articles

Cited by

References

    1. Berrada Z. L., Lin S. Y., Rodwell T. C., Nguyen D., Schecter G. F., Pham L., et al. (2016). Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex. Diagn. Microbiol. Infect. Dis. 85 177–181. 10.1016/j.diagmicrobio.2016.01.019 - DOI - PMC - PubMed
    1. Campbell P. J., Morlock G. P., Sikes R. D., Dalton T. L., Metchock B., Starks A. M., et al. (2011). Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55 2032–2041. 10.1128/AAC.01550-10 - DOI - PMC - PubMed
    1. Cavusoglu C., Karaca-Derici Y., Bilgic A. (2004). In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Clin. Microbiol. Infect. 10 662–665. 10.1111/j.1469-0691.2004.00917.x - DOI - PubMed
    1. CDC (2013). Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis. Atlanta, GA: Centers for Disease Control and Prevention.
    1. Chen H. Y., Yu M. C., Huang W. L., Wu M. H., Chang Y. L., Che C. R., et al. (2012). Molecular detection of rifabutin-susceptible Mycobacterium tuberculosis. J. Clin. Microbiol. 50 2085–2088. 10.1128/JCM.00652-12 - DOI - PMC - PubMed

LinkOut - more resources